These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 975720)

  • 21. Aminopyrine breath test and zonal hepatic damage in rats.
    Farag MM; Volicer L
    Pharmacology; 1985; 31(6):309-17. PubMed ID: 3936064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The determination of aminopyrin elimination for control of the metabolic capacity of the liver in man.
    Haustein KO; Hüller G; Sensing H
    Eur J Clin Invest; 1982 Apr; 12(2):157-64. PubMed ID: 6807687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of age and sex on the N-demethylation rate of 14C-aminopyrine, studied by the breath test.
    Pirotte J; El Allaf D
    Digestion; 1983; 28(4):210-5. PubMed ID: 6671482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noninvasive diagnosis and prognosis of liver cirrhosis: a comparison of biological scores, elastometry, and metabolic liver function tests.
    Forestier J; Dumortier J; Guillaud O; Ecochard M; Roman S; Boillot O; Lutringer D; Scoazec JY; Subtil F; Mion F
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):532-40. PubMed ID: 20164779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breath 14CO2 after intravenous administration of [14C]aminopyrine in liver diseases.
    Pauwels S; Geubel AP; Dive C; Beckers C
    Dig Dis Sci; 1982 Jan; 27(1):49-56. PubMed ID: 6802621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aminopyrine N-demethylation by rats with liver cirrhosis. Evidence for the intact cell hypothesis. A morphometric-functional study.
    Reichen J; Arts B; Schafroth U; Zimmermann A; Zeltner B; Zysset T
    Gastroenterology; 1987 Oct; 93(4):719-26. PubMed ID: 3623018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aminopyrine metabolism in the presence of hyperbilirubinemia due to cholestasis or hepatocellular disease. Combined use of laboratory tests to study disease-induced alterations in drug disposition.
    Hepner GW; Vesell ES
    Clin Pharmacol Ther; 1977 May; 21(5):620-6. PubMed ID: 870274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of liver function by the aminopyrine breath test.
    Villeneuve JP; Arsène D; Huet PM
    Clin Invest Med; 1983; 6(1):5-9. PubMed ID: 6403268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 13C-aminopyrine demethylation is decreased in cirrhotic patients with normal biochemical markers.
    Afolabi P; Wright M; Wootton SA; Jackson AA
    Isotopes Environ Health Stud; 2013; 49(3):346-56. PubMed ID: 23799253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental hepatobiliary injury. Comparison of in vivo drug elimination with in vitro drug-metabolizing enzyme capacity in the rat.
    Willson RA; Hart FE; Hew JT
    Dig Dis Sci; 1981 Jan; 26(1):50-9. PubMed ID: 6780282
    [No Abstract]   [Full Text] [Related]  

  • 31. The aminopyrine breath test as a measure of liver function. A quantitative description of its metabolic basis in normal subjects.
    Irving CS; Schoeller DA; Nakamura KI; Baker AL; Klein PD
    J Lab Clin Med; 1982 Sep; 100(3):356-73. PubMed ID: 6809872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early diagnosis of alcoholic cirrhosis by the aminopyrine breath test.
    Saunders JB; Lewis KO; Paton A
    Gastroenterology; 1980 Jul; 79(1):112-4. PubMed ID: 6769747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver function in physically trained subjects: galactose elimination capacity, plasma disappearance of indocyanine green, and aminopyrine metabolism in long-distance runners.
    Ducry JJ; Howald H; Zysset T; Bircher J
    Dig Dis Sci; 1979 Mar; 24(3):192-6. PubMed ID: 456207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A [14C]phenacetin breath test to measure hepatic function in man.
    Breen KJ; Bury RW; Calder IV; Desmond PV; Peters M; Mashford ML
    Hepatology; 1984; 4(1):47-52. PubMed ID: 6420304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal aminopyrine metabolism in patients with hepatic neoplasm. Detection by breath test.
    Hepner GW; Uhlin SR; Lipton A; Harvey HA; Rohrer V
    JAMA; 1976 Oct; 236(14):1587-90. PubMed ID: 989131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma levels of parent drug and metabolites in the intravenous aminopyrine breath test.
    Breyer-Pfaff U; Harder M; Egberts EH
    Eur J Clin Pharmacol; 1982; 21(6):521-8. PubMed ID: 6804246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Liver metabolism of indocyanine green and aminopyrine in liver cirrhosis: relations with functioning liver cell mass].
    Bolognesi M; Merkel C; Angeli P; Caregaro L; Gatta A
    Minerva Med; 1988 Dec; 79(12):1035-41. PubMed ID: 3211355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial dysfunction in alcoholic patients as assessed by breath analysis.
    Lauterburg BH; Liang D; Schwarzenbach FA; Breen KJ
    Hepatology; 1993 Mar; 17(3):418-22. PubMed ID: 8444415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The in vivo measurement of expired 14CO2 derived from the N-demethylation of aminopyrine as a reflection of the in vitro hepatic cytochrome P-450 drug-metabolism activity in rats.
    Kotake AN; Schreider BD; Latts JR
    Drug Metab Dispos; 1982; 10(3):251-8. PubMed ID: 6125358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of the aminopyrine breath test in cirrhotic patients.
    Villeneuve JP; Infante-Rivard C; Ampelas M; Pomier-Layrargues G; Huet PM; Marleau D
    Hepatology; 1986; 6(5):928-31. PubMed ID: 3758945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.